Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02637856 |
|---|---|
| Brief Title: | A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) |
| First Submitted : | December 18, 2015 |
| First Submitted that Met QC Criteria : | December 18, 2015 |
| First Posted : | December 22, 2015 (Estimate) |
| Results First Submitted : | April 15, 2020 |
| Results First Submitted that Met QC Criteria : | May 8, 2020 |
| Results First Posted : | May 26, 2020 |
| Last Update Submitted that Met QC Criteria : | May 8, 2020 |
| Last Update Posted : | May 26, 2020 |